
|Articles|October 1, 2002
Intracranial tumors show neuro-ophthalmic manifestations
The ophthalmologist may be the first medical encounter for a patient with an intracranial tumor. Localization of the lesion is critical, and "where the lesion is" at the diagnosis stage is more important sometimes than "what the lesion is."
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
2
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
3
Collarettes common but largely stable in moderate-to-severe dry eye patients
4
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
5

















































.png)


